We developed an ELISPOT assay for evaluating Middle East respiratory syndrome coronavirus (MERS-CoV)‒specific T-cell responses in dromedary camels. After single modified vaccinia virus Ankara-MERS-S vaccination, seropositive camels showed increased levels of MERS-CoV‒specific T cells and antibodies, indicating suitability of camel vaccinations in disease-endemic areas as a promising approach to control infection.
All Keywords
【저자키워드】 viruses, respiratory infections, zoonoses, coronavirus, vaccination, MERS-CoV, Spike protein, Dubai, Middle East respiratory syndrome Coronavirus, modified vaccinia virus Ankara, ELISpot assay, T-cell responses, MVA-MERS-S, dromedary camels, MVA, MVA expressing full-length MERS-CoV spike protein as antigen,
【저자키워드】 viruses, respiratory infections, zoonoses, coronavirus, vaccination, MERS-CoV, Spike protein, Dubai, Middle East respiratory syndrome Coronavirus, modified vaccinia virus Ankara, ELISpot assay, T-cell responses, MVA-MERS-S, dromedary camels, MVA, MVA expressing full-length MERS-CoV spike protein as antigen,